AI assistant
INVION LIMITED — Capital/Financing Update 2021
Nov 22, 2021
65148_rns_2021-11-22_9865767a-e921-4057-b1f6-58afa45b6662.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
INVION LIMITED
Announcement Type
New announcement
Date of this announcement
23/11/2021
The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A non pro rata offer of securities under a disclosure document or product disclosure statement (PDS)
Total number of +securities proposed to be issued for a non pro rata offer of securities under a disclosure document or product disclosure statement (PDS)
| Maximum Number of | ||
|---|---|---|
| ASX +security code | +Security description | +securities to be issued |
| New class-code to be | Listed options exercisable at $0.04 expiring 18 months from | 68181819 |
| confirmed | date of issue |
Closing date for receipt of acceptances
10/12/2021
Proposed +issue date
14/12/2021
Refer to next page for full details of the announcement
Proposed issue of securities
1 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of +Entity
INVION LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type Registration Number ABN 76094730417
1.3 ASX issuer code
IVX
1.4 The announcement is
==> picture [8 x 8] intentionally omitted <==
New announcement
1.5 Date of this announcement
23/11/2021
1.6 The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A non-+pro rata offer of +securities under a +disclosure document or +PDS
Proposed issue of securities
2 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 5 - Details of proposed non-pro rata offer under a disclosure document or PDS
Part 5A - Conditions
5A.1 Do any external approvals need to be obtained or other conditions satisfied before the non-pro rata offer of +securities under a +disclosure document or + PDS can proceed on an unconditional basis? No
Part 5B - Offer details
| Is the proposed security a 'New | Will the proposed issue of this |
|---|---|
| class' (+securities in a class that is | +security include an offer of |
| not yet quoted or recorded by ASX) | attaching +securities? |
| or an 'Existing class' (additional | No |
| securities in a class that is already | |
| quoted or recorded by ASX)? | |
| New class | |
| Details of +securities proposed to be issued | |
| ISIN Code (if Issuer is a foreign company and +securities are non CDIs) | |
| Have you received confirmation from | Will the entity be seeking quotation |
| ASX that the terms of the proposed | of the 'new' class of +securities on |
| +securities are appropriate and | ASX? |
| equitable under listing rule 6.1? | Yes |
| No | |
| ASX +security code | +Security description |
| New class-code to be confirmed | Listed options exercisable at $0.04 expiring 18 months from date of issue |
| +Security type | |
| Options | |
| The number of +securities to be offered under the +disclosure document or | |
| +PDS | |
| 68,181,819 |
Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)? No
Proposed issue of securities
3 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
| Proposed issue of securities | Proposed issue of securities | |
|---|---|---|
| Will individual security holders be required to accept the offer for a | ||
| minimum number or value of +securities (i.e. a minimum acceptance | ||
| condition)? | ||
| No | ||
| Will individual security holders be limited to accepting the offer for a | ||
| maximum number or value of +securities (i.e. a maximum acceptance | ||
| condition)? | ||
| No | ||
| Offer price details | ||
| Has the offer price been determined? | ||
| Yes | ||
| In what currency will the offer be | What is the offer price per +security? | |
| made? | AUD 0.04000 | |
| AUD - Australian Dollar | ||
| Oversubscription & Scale back details | ||
| Will the entity be entitled to accept over-subscriptions? | ||
| No | ||
| Will a scale back be applied if the offer | is over-subscribed? | |
| No | ||
| Will all the +securities issued in this class rank equally in all respects from | ||
| their issue date? | ||
| Yes | ||
| Options details | ||
| +Security currency | Exercise price | Expiry date |
| AUD - Australian Dollar | AUD 0.0400 | 14/6/2023 |
| Details of the type of +security that will be issued if the option is exercised | ||
| IVX : ORDINARY FULLY PAID | ||
| Number of securities that will be issued if the option is exercised | ||
| 68,181,819 fully paid ordinary shares | ||
| Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities | ||
| proposed to be issued or provide the information by separate announcement. |
Proposed issue of securities
4 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 5C - Timetable
5C.1 Lodgement date of +disclosure document or +PDS with ASIC
22/11/2021
5C.2 Date when +disclosure document or +PDS and acceptance forms will be made available to investors
30/11/2021
5C.3 Offer open date
30/11/2021
5C.4 Closing date for receipt of acceptances
10/12/2021
5C.6 Proposed +issue date
14/12/2021
Part 5D - Listing Rule requirements
5D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? No
5D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? Yes
5D.1b ( i ) How many +securities are proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?
68,181,819 listed options
5D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No
5D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No
Part 5E - Fees and expenses
5E.1 Will there be a lead manager or broker to the proposed offer? No
5E.2 Is the proposed offer to be underwritten? No
Proposed issue of securities
5 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
5E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? No
5E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer
Part 5F - Further Information
5F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue
Full details per the ASX announcement dated 16 November 2021.Use of funds include conditional agreements to co-develop Photosoft¿ technology for cancer & related diseases and exclusive distribution rights to the technology in Asia Pacific.
5F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful? No
5F.2 Please explain the entity's allocation policy for the offer, including whether or not acceptances from existing +security holders will be given priority
Participants in the SPP announced 16 November 2021 will be offered 1 free attaching option for every 2 New Shares subscribed, exercisable at 4 cents and expiring 18 months from the issue date.
5F.3 URL on the entity's website where investors can download the +disclosure document or +PDS
http://inviongroup.com/asx-announcements/
5F.4 Any other information the entity wishes to provide about the proposed offer
Proposed issue of securities
6 / 6